Stroke prevention and cognitive reserve: Emerging approaches to modifying risk and delaying onset of dementia

Frontiers in Neurology

Volumn 4 MAR, Issue , 2013, Pages

  Willis, Kevin J ^a   Hakim, Antoine M ^a,b,c  

^a Canadian Stroke Network   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alzheimer's; Cognitive reserve; Dementia; Prevention; Stroke

Indexed keywords

AMYLOID PROTEIN;

AGE DISTRIBUTION; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COGNITIVE RESERVE; COGNITIVE THERAPY; DEMENTIA; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; DISEASE CONTROL; EDUCATION; EPISODIC MEMORY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; MICROEMBOLISM; MULTIINFARCT DEMENTIA; PATHOGENESIS; PREVALENCE; PROTEIN METABOLISM; PUBLIC HEALTH; RISK FACTOR; SOCIAL NETWORK; SOCIAL PSYCHOLOGY; VASCULAR DISEASE;

EID: 84878804041     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00013     Document Type: Article

References (78)

1. Acevedo, A., and Loewenstein, D. A. (2007). Nonpharmacological cognitive interventions in aging and dementia. J. Geriatr. Psychiatry Neurol. 20, 239-249.
2. Ahlskog, J. E., Geda, Y. E., Graff-Radford, N. R., and Petersen, R. C. (2011). Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin. Proc. 86, 876-884.
3. Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., et al. (2002). Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 288, 2271-2281.
4. Barnes, D. E., and Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819-828.
5. BBC News. (2012). Alzheimer's Disease Drug Shelved after Trial Failure. Available at: http://www.bbc.co.uk/news/world-us-canada-19159167 [accessed August 6, 2012].
6. Bennett, D. A., Schneider, J. A., Tang, Y., Arnold, S. E., and Wilson, R. S. (2006). The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 5, 406-412.
7. Bialystok, E., Craik, F. I., and Freedman, M. (2007). Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia 45, 459-464.
8. Bialystok, E., Craik, F. I., and Luk, G. (2012). Bilingualism: consequences for mind and brain. Trends Cogn. Sci. (Regul. Ed.) 16, 240-250.
9. Blum, S., Luchsinger, J. A., Manly, J. J., Schupf, N., Stern, Y., Brown, T. R., et al. (2012). Memory after silent stroke: hippocampus and infarcts both matter. Neurology 78, 38-46.
10. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191.
11. Buschert, V., Bokde, A. L. W., and Hampel, H. (2010). Cognitive intervention in Alzheimer disease. Nat. Rev. Neurol. 6, 508-517.
12. Chui, H. C., Zheng, L., Reed, B. R., Vinters, H. V., and Mack, W. J. (2012). Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res. Ther. 4, 1.
13. Costandi, M. (2012). Fantasy fix. New Sci. 213, 39-41.
14. Dardiotis, E., Giamouzi, G., Mastrogiannis, D., Vogiatzi, C., Skoularigis, J., Triposkiadis, F., et al. (2012). Cognitive impairment in heart failure. Cardiol. Res. Pract. 2012, 595821.
15. Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R., et al. (2011). Risk factors and preventive interventions for Alzheimer disease. Arch. Neurol. 68, 1185-1190.
16. de la Torre, J. C. (2004). Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 3, 184-190.
17. de la Torre, J. C. (2010). Alzheimer's disease is incurable but preventable. J. Alzheimers Dis. 20, 861-870.
18. Debette, S., and Markus, H. S. (2010). The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341, c3666.
19. DeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., et al. (2005). Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol. Aging 26, 491-510.
20. Denkinger, M. D., Nikolaus, T., Denkinger, C., and Lukas, A. (2012). Physical activity for the prevention of cognitive decline. Current evidence from observational and controlled studies. Z. Gerontol. Geriatr. 45, 11-16.
21. Deschaintre, Y., Richard, F., Leys, D., and Pasquier, F. (2009). Treatment of vascular risk factors is associated with slower decline in Alzheimer's disease. Neurology 73, 674-680.
22. Dowling, N. M., Tomaszewski-Farias, S., Reed, B. R., Sonnen, J. A., Strauss, M. E., Schneider, J. A., et al. (2011). Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J. Int. Neuropsychol. Soc. 17, 602-614.
23. Esiri, M. M., and Chance, S. A. (2012). Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease. Alzheimers Res. Ther. 4, 7.
24. Goldberg, I., Auriel, E., Russell, D., and Korczyn, A. D. (2012). Microembolism, silent brain infarcts and dementia. J. Neurol. Sci. 322, 250-253.
25. Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., et al. (2011). Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 517-584.
26. Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., et al. (2011). Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713.
27. Grinberg, L. T., and Heinsen, H. (2010). Toward a pathological definition of vascular dementia. J. Neurol. Sci. 299, 136-138.
28. Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., et al. (2006). National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220-2241.
29. Hakim, A. M. (2011). Depression, strokes and dementia: new biological insights into an unfortunate pathway. Cardiovasc. Psychiatry Neurol. 2011, 649629.
30. Hendrie, H. C., Ogunniyi, A., Hall, K. S., Baiyewu, O., Unverzagt, F. W., Gureje, O., et al. (2001). Incidence of dementia and Alzheimer disease in 2 communities. JAMA 285, 739-747.
31. Jeerakathil, T., Wolf, P. A., Beiser, A., Hald, J. K., Au, R., Kase, C. S., et al. (2004). Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham study. Stroke 35, 1831-1835.
32. Korczyn, A. D., Vakhapova, V., and Grinberg, L. T. (2012). Vascular dementia. J. Neurol. Sci. 322, 2-10.
33. Kroke, A., Boeing, H., Rossnagel, K., and Willich, S. N. (2003). History of the concept of 'levels of evidence' and their current status in relation to primary prevention through lifestyle interventions. Public Health Nutr. 7, 279-284.
34. Lee, E. B. (2011). Obesity, leptin, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1243, 15-29.
35. Leys, D., Hénon, H., MacKowiak-Cordoliani, M.-A., and Pasquier, F. (2005). Poststroke dementia. Lancet Neurol. 4, 752-759.
36. Lu, F. P., Lin, K. P., and Kuo, H. K. (2009). Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE 4:e4144. doi:10.1371/journal.pone.0004144
37. Mangialasche, F., Kivipelto, M., Solomon, A., and Fratiglioni, L. (2012). Dementia prevention: current epidemiological evidence and future perspective. Alzheimers Res. Ther. 4, 6.
38. Meng, X., and D'Arcy, C. (2012). Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analysis and qualitative analysis. PLoS ONE 7:e38268. doi:10.1371/journal.pone.0038268
39. Moller, J. T., Cluitmans, P., Rasmussen, L. S., Houx, P., Rasmussen, H., Canet, J., et al. (1998). Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study: international study of postoperative cognitive dysfunction. Lancet 351, 857-861.
40. Nagai, M., Hoshide, S., and Kario, K. (2010). Hypertension and dementia. Am. J. Hypertens. 23, 116-124.
41. National Institutes of Health. (2010). Consensus Development Conference Statement on Preventing Alzheimer's Disease and Cognitive Decline. Bethesda: National Institutes of Health.
42. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175.
43. Ojala-Oksala, J., Jokinen, H., Kopsi, V., Lehtonen, K., Luukkonen, L., Paukkunen, A., et al. (2012). Educational history is an independent predictor of cognitive deficits and long-term survival in postacute patients with mild to moderate ischemic stroke. Stroke 43, 2931-2935.
44. Owen, A. M., Hampshire, A., Grahn, J. A., Stenton, R., Dajani, S., Burns, A. S., et al. (2010). Putting brain training to the test. Nature 465, 775-778.
45. Patterson, C., Feightner, J., Garcia, A., and MacKnight, C. (2007). General risk factors for dementia: a systematic evidence review. Alzheimers Dement. 3, 341-347.
46. Pendlebury, S. T., and Rothwell, P. M. (2009). Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 8, 1006-1018.
47. Pimentel-Coelho, P. M., and Rivest, S. (2012). The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur. J. Neurosci. 35, 1917-1937.
48. Poels, M. M., Vernooij, M. W., Ikram, M. A., Hofman, A., Krestin, G. P., van der Lugt, A., et al. (2010). Prevalence and risk factors of cerebral microbleeds and update of the Rotterdam Scan Study. Stroke 41, s103-s106.
49. Prince, M., Acosta, D., Ferri, C. P., Guerra, M., Huang, Y., Llibre-Rodriguez, J. J., et al. (2012). Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study. Lancet 380, 50-58.
50. Prins, N. D., van Dijk, E. J., den Heijer, T., Vermeer, S. E., Jolles, J., Koudstaal, P. J., et al. (2005). Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034-2041.
51. Purandare, N., Burns, A., Daly, K. J., Hardicre, J., Morris, J., Macfarlane, G., et al. (2006). Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. BMJ 332, 1119-1124.
52. Purandare, N., Burns, A., Morris, J., Perry, E. P., Wren, J., and McCollum, C. (2012). Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia. Am. J. Psychiatry 169, 300-308.
53. Qiu, C. (2012). Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. J. Alzheimers Dis. 32, 721-731.
54. Romàn, G. C. (2002a). On the history of lacunes, etat criblé, and the white matter lesions of vascular dementia. Cerebrovasc. Dis. 13, 1-6.
55. Romàn, G. C. (2002b). Vascular dementia may be the most common form of dementia in the elderly. J. Neurol. Sci. 203-204, 7-10.
56. Romàn, G. C., Nash, D. T., and Fillit, H. (2012). Translating current knowledge into dementia prevention. Alzheimer Dis. Assoc. Disord. 4, 295-299.
57. Rusanen, M., Kivipelto, M., Quesenberry, C. P., Zhou, J., and Whitmer, R. A. (2010). Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch. Intern. Med. 171, 333-339.
58. Schneider, J. A., Arvanitakis, Z., Bang, W., and Bennett, D. A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197-2204.
59. Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., and Bennett, D. A. (2009). The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66, 200-208.
60. Schneider, J. A., and Bennett, D. A. (2010). Where vascular meets neurodegenerative disease. Stroke 41, s144-s146.
61. Schrijvers, E. M., Verhaaren, B. F., Koudstaal, P. J., Hofman, A., Ikram, M. A., and Breteler, M. M. (2012). Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 78, 1456-1463.
62. Snowdon, D. A., Greiner, L. H., Mortimer, J. A., Riley, K. P., Greiner, P. A., and Markesbery, W. R. (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817.
63. Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., et al. (2011). Diet and Alzheimer's disease risk factors for prevention: the current evidence. Expert Rev. Neurother. 11, 677-708.
64. Spence, D. (2012). Bad medicine: dementia. BMJ 344, e3859.
65. Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 8, 448-460.
66. Stern, Y. (2006). Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20, 112-117.
67. Sundar, U., and Adwani, S. (2010). Post-stroke cognitive impairment at 3 months. Ann Indian Acad. Neurol. 13, 42-46.
68. Teich, A. F., and Arancio, O. (2012). Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? Biochem. J. 446, 165-177.
69. van Vliet, P. (2012). Cholesterol and late-life cognitive decline. J. Alzheimers Dis. 30, s147-s162.
70. Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., et al. (2012). Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 11, 851-859.
71. Vermeer, S. E., Longstreth, W. T., and Koudstaal, P. J. (2007). Silent brain infarcts: a systematic review. Lancet Neurol. 6, 611-619.
72. Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., and Breteler, M. M. (2003a). Silent brain infarcts and the risk of dementia and cognitive decline: the Rotterdam Scan Study. N. Engl. J. Med. 348, 1215-1222.
73. Vermeer, S. E., Hollander, M., van Dijk, E. J., Hofman, A., Koudstaal, P. J., and Breteler, M. M. (2003b). Silent brain infarcts and white-matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34, 1126-1129.
74. Viswanathan, A., and Chabriat, H. (2006). Cerebral microhemorrhage. Stroke 37, 550-555.
75. Werring, D. J., Frazer, D. W., Coward, L. J., Losseff, N. A., Watt, H., Cipolotti, L., et al. (2004). Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 127, 2265-2275.
76. Willis, B. L., Gao, A., Leonard, D., Defina, L. F., and Berry, J. D. (2012). Midlife fitness and the development of chronic conditions in later life. Arch. Intern. Med. 172, 1333-1340.
77. World Health Organization and Alzheimer's Disease International. (2012). Dementia: a Public Health Priority. Geneva: World Health Organization Press.
78. Zieren, N., Duering, M., Peters, N., Reyes, S., Jouvent, E., Hervé, D., et al. (2013). Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol. Aging 34, 400-407